Product Code:203161
Published Date: Jan 05,2022
Pages: 101
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
As the global economy mends, the 2021 growth of Gastric Cancer Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Gastric Cancer Drugs market size is USD million in 2022 from USD 1164.7 million in 2021, with a change of % between 2021 and 2022. The global Gastric Cancer Drugs market size will reach USD 2161.1 million in 2028, growing at a CAGR of 9.2% over the analysis period. The United States Gastric Cancer Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastric Cancer Drugs market, reaching US$ million by the year 2028. As for the Europe Gastric Cancer Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period. Global main Gastric Cancer Drugs players cover Sanofi, Eli Lilly, F. Hoffmann-La Roche, and Otsuka Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. This report presents a comprehensive overview, market shares, and growth opportunities of Gastric Cancer Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6 Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7. Hospitals Clinics Other This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include Sanofi Eli Lilly F. Hoffmann-La Roche Otsuka Pharmaceutical Novartis Amgen Merck AstraZeneca Boehringer Ingelheim Daiichi-Sankyo Bayer HealthCare
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastric Cancer Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gastric Cancer Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gastric Cancer Drugs by Country/Region, 2017, 2022 & 2028
2.2 Gastric Cancer Drugs Segment by Type
2.2.1 Doxorubicin Hydrochloride
2.2.2 Sunitinib
2.2.3 Docetaxel
2.2.4 Mitomycin
2.2.5 Fluorouracil
2.2.6 Imatinib
2.2.7 Trastuzumab
2.3 Gastric Cancer Drugs Sales by Type
2.3.1 Global Gastric Cancer Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Gastric Cancer Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gastric Cancer Drugs Sale Price by Type (2017-2022)
2.4 Gastric Cancer Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Gastric Cancer Drugs Sales by Application
2.5.1 Global Gastric Cancer Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Gastric Cancer Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gastric Cancer Drugs Sale Price by Application (2017-2022)
3 Global Gastric Cancer Drugs by Company
3.1 Global Gastric Cancer Drugs Breakdown Data by Company
3.1.1 Global Gastric Cancer Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Gastric Cancer Drugs Sales Market Share by Company (2020-2022)
3.2 Global Gastric Cancer Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Gastric Cancer Drugs Revenue by Company (2020-2022)
3.2.2 Global Gastric Cancer Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Gastric Cancer Drugs Sale Price by Company
3.4 Key Manufacturers Gastric Cancer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastric Cancer Drugs Product Location Distribution
3.4.2 Players Gastric Cancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gastric Cancer Drugs by Geographic Region
4.1 World Historic Gastric Cancer Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Gastric Cancer Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gastric Cancer Drugs Annual Revenue by Geographic Region
4.2 World Historic Gastric Cancer Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Gastric Cancer Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gastric Cancer Drugs Annual Revenue by Country/Region
4.3 Americas Gastric Cancer Drugs Sales Growth
4.4 APAC Gastric Cancer Drugs Sales Growth
4.5 Europe Gastric Cancer Drugs Sales Growth
4.6 Middle East & Africa Gastric Cancer Drugs Sales Growth
5 Americas
5.1 Americas Gastric Cancer Drugs Sales by Country
5.1.1 Americas Gastric Cancer Drugs Sales by Country (2017-2022)
5.1.2 Americas Gastric Cancer Drugs Revenue by Country (2017-2022)
5.2 Americas Gastric Cancer Drugs Sales by Type
5.3 Americas Gastric Cancer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastric Cancer Drugs Sales by Region
6.1.1 APAC Gastric Cancer Drugs Sales by Region (2017-2022)
6.1.2 APAC Gastric Cancer Drugs Revenue by Region (2017-2022)
6.2 APAC Gastric Cancer Drugs Sales by Type
6.3 APAC Gastric Cancer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gastric Cancer Drugs by Country
7.1.1 Europe Gastric Cancer Drugs Sales by Country (2017-2022)
7.1.2 Europe Gastric Cancer Drugs Revenue by Country (2017-2022)
7.2 Europe Gastric Cancer Drugs Sales by Type
7.3 Europe Gastric Cancer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastric Cancer Drugs by Country
8.1.1 Middle East & Africa Gastric Cancer Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gastric Cancer Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Gastric Cancer Drugs Sales by Type
8.3 Middle East & Africa Gastric Cancer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastric Cancer Drugs
10.3 Manufacturing Process Analysis of Gastric Cancer Drugs
10.4 Industry Chain Structure of Gastric Cancer Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastric Cancer Drugs Distributors
11.3 Gastric Cancer Drugs Customer
12 World Forecast Review for Gastric Cancer Drugs by Geographic Region
12.1 Global Gastric Cancer Drugs Market Size Forecast by Region
12.1.1 Global Gastric Cancer Drugs Forecast by Region (2023-2028)
12.1.2 Global Gastric Cancer Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastric Cancer Drugs Forecast by Type
12.7 Global Gastric Cancer Drugs Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Gastric Cancer Drugs Product Offered
13.1.3 Sanofi Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Gastric Cancer Drugs Product Offered
13.2.3 Eli Lilly Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 F. Hoffmann-La Roche
13.3.1 F. Hoffmann-La Roche Company Information
13.3.2 F. Hoffmann-La Roche Gastric Cancer Drugs Product Offered
13.3.3 F. Hoffmann-La Roche Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 F. Hoffmann-La Roche Main Business Overview
13.3.5 F. Hoffmann-La Roche Latest Developments
13.4 Otsuka Pharmaceutical
13.4.1 Otsuka Pharmaceutical Company Information
13.4.2 Otsuka Pharmaceutical Gastric Cancer Drugs Product Offered
13.4.3 Otsuka Pharmaceutical Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Otsuka Pharmaceutical Main Business Overview
13.4.5 Otsuka Pharmaceutical Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Gastric Cancer Drugs Product Offered
13.5.3 Novartis Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Gastric Cancer Drugs Product Offered
13.6.3 Amgen Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Gastric Cancer Drugs Product Offered
13.7.3 Merck Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Gastric Cancer Drugs Product Offered
13.8.3 AstraZeneca Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Gastric Cancer Drugs Product Offered
13.9.3 Boehringer Ingelheim Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Daiichi-Sankyo
13.10.1 Daiichi-Sankyo Company Information
13.10.2 Daiichi-Sankyo Gastric Cancer Drugs Product Offered
13.10.3 Daiichi-Sankyo Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Daiichi-Sankyo Main Business Overview
13.10.5 Daiichi-Sankyo Latest Developments
13.11 Bayer HealthCare
13.11.1 Bayer HealthCare Company Information
13.11.2 Bayer HealthCare Gastric Cancer Drugs Product Offered
13.11.3 Bayer HealthCare Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bayer HealthCare Main Business Overview
13.11.5 Bayer HealthCare Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Gastric Cancer Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Gastric Cancer Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Doxorubicin Hydrochloride Table 4. Major Players of Sunitinib Table 5. Major Players of Docetaxel Table 6. Major Players of Mitomycin Table 7. Major Players of Fluorouracil Table 8. Major Players of Imatinib Table 9. Major Players of Trastuzumab Table 10. Global Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs) Table 11. Global Gastric Cancer Drugs Sales Market Share by Type (2017-2022) Table 12. Global Gastric Cancer Drugs Revenue by Type (2017-2022) & ($ million) Table 13. Global Gastric Cancer Drugs Revenue Market Share by Type (2017-2022) Table 14. Global Gastric Cancer Drugs Sale Price by Type (2017-2022) & (USD/Pcs) Table 15. Global Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs) Table 16. Global Gastric Cancer Drugs Sales Market Share by Application (2017-2022) Table 17. Global Gastric Cancer Drugs Revenue by Application (2017-2022) Table 18. Global Gastric Cancer Drugs Revenue Market Share by Application (2017-2022) Table 19. Global Gastric Cancer Drugs Sale Price by Application (2017-2022) & (USD/Pcs) Table 20. Global Gastric Cancer Drugs Sales by Company (2020-2022) & (K Pcs) Table 21. Global Gastric Cancer Drugs Sales Market Share by Company (2020-2022) Table 22. Global Gastric Cancer Drugs Revenue by Company (2020-2022) ($ Millions) Table 23. Global Gastric Cancer Drugs Revenue Market Share by Company (2020-2022) Table 24. Global Gastric Cancer Drugs Sale Price by Company (2020-2022) & (USD/Pcs) Table 25. Key Manufacturers Gastric Cancer Drugs Producing Area Distribution and Sales Area Table 26. Players Gastric Cancer Drugs Products Offered Table 27. Gastric Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 28. New Products and Potential Entrants Table 29. Mergers & Acquisitions, Expansion Table 30. Global Gastric Cancer Drugs Sales by Geographic Region (2017-2022) & (K Pcs) Table 31. Global Gastric Cancer Drugs Sales Market Share Geographic Region (2017-2022) Table 32. Global Gastric Cancer Drugs Revenue by Geographic Region (2017-2022) & ($ millions) Table 33. Global Gastric Cancer Drugs Revenue Market Share by Geographic Region (2017-2022) Table 34. Global Gastric Cancer Drugs Sales by Country/Region (2017-2022) & (K Pcs) Table 35. Global Gastric Cancer Drugs Sales Market Share by Country/Region (2017-2022) Table 36. Global Gastric Cancer Drugs Revenue by Country/Region (2017-2022) & ($ millions) Table 37. Global Gastric Cancer Drugs Revenue Market Share by Country/Region (2017-2022) Table 38. Americas Gastric Cancer Drugs Sales by Country (2017-2022) & (K Pcs) Table 39. Americas Gastric Cancer Drugs Sales Market Share by Country (2017-2022) Table 40. Americas Gastric Cancer Drugs Revenue by Country (2017-2022) & ($ Millions) Table 41. Americas Gastric Cancer Drugs Revenue Market Share by Country (2017-2022) Table 42. Americas Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs) Table 43. Americas Gastric Cancer Drugs Sales Market Share by Type (2017-2022) Table 44. Americas Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs) Table 45. Americas Gastric Cancer Drugs Sales Market Share by Application (2017-2022) Table 46. APAC Gastric Cancer Drugs Sales by Region (2017-2022) & (K Pcs) Table 47. APAC Gastric Cancer Drugs Sales Market Share by Region (2017-2022) Table 48. APAC Gastric Cancer Drugs Revenue by Region (2017-2022) & ($ Millions) Table 49. APAC Gastric Cancer Drugs Revenue Market Share by Region (2017-2022) Table 50. APAC Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs) Table 51. APAC Gastric Cancer Drugs Sales Market Share by Type (2017-2022) Table 52. APAC Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs) Table 53. APAC Gastric Cancer Drugs Sales Market Share by Application (2017-2022) Table 54. Europe Gastric Cancer Drugs Sales by Country (2017-2022) & (K Pcs) Table 55. Europe Gastric Cancer Drugs Sales Market Share by Country (2017-2022) Table 56. Europe Gastric Cancer Drugs Revenue by Country (2017-2022) & ($ Millions) Table 57. Europe Gastric Cancer Drugs Revenue Market Share by Country (2017-2022) Table 58. Europe Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs) Table 59. Europe Gastric Cancer Drugs Sales Market Share by Type (2017-2022) Table 60. Europe Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs) Table 61. Europe Gastric Cancer Drugs Sales Market Share by Application (2017-2022) Table 62. Middle East & Africa Gastric Cancer Drugs Sales by Country (2017-2022) & (K Pcs) Table 63. Middle East & Africa Gastric Cancer Drugs Sales Market Share by Country (2017-2022) Table 64. Middle East & Africa Gastric Cancer Drugs Revenue by Country (2017-2022) & ($ Millions) Table 65. Middle East & Africa Gastric Cancer Drugs Revenue Market Share by Country (2017-2022) Table 66. Middle East & Africa Gastric Cancer Drugs Sales by Type (2017-2022) & (K Pcs) Table 67. Middle East & Africa Gastric Cancer Drugs Sales Market Share by Type (2017-2022) Table 68. Middle East & Africa Gastric Cancer Drugs Sales by Application (2017-2022) & (K Pcs) Table 69. Middle East & Africa Gastric Cancer Drugs Sales Market Share by Application (2017-2022) Table 70. Key Market Drivers & Growth Opportunities of Gastric Cancer Drugs Table 71. Key Market Challenges & Risks of Gastric Cancer Drugs Table 72. Key Industry Trends of Gastric Cancer Drugs Table 73. Gastric Cancer Drugs Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Gastric Cancer Drugs Distributors List Table 76. Gastric Cancer Drugs Customer List Table 77. Global Gastric Cancer Drugs Sales Forecast by Region (2023-2028) & (K Pcs) Table 78. Global Gastric Cancer Drugs Sales Market Forecast by Region Table 79. Global Gastric Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Global Gastric Cancer Drugs Revenue Market Share Forecast by Region (2023-2028) Table 81. Americas Gastric Cancer Drugs Sales Forecast by Country (2023-2028) & (K Pcs) Table 82. Americas Gastric Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions) Table 83. APAC Gastric Cancer Drugs Sales Forecast by Region (2023-2028) & (K Pcs) Table 84. APAC Gastric Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions) Table 85. Europe Gastric Cancer Drugs Sales Forecast by Country (2023-2028) & (K Pcs) Table 86. Europe Gastric Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions) Table 87. Middle East & Africa Gastric Cancer Drugs Sales Forecast by Country (2023-2028) & (K Pcs) Table 88. Middle East & Africa Gastric Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions) Table 89. Global Gastric Cancer Drugs Sales Forecast by Type (2023-2028) & (K Pcs) Table 90. Global Gastric Cancer Drugs Sales Market Share Forecast by Type (2023-2028) Table 91. Global Gastric Cancer Drugs Revenue Forecast by Type (2023-2028) & ($ Millions) Table 92. Global Gastric Cancer Drugs Revenue Market Share Forecast by Type (2023-2028) Table 93. Global Gastric Cancer Drugs Sales Forecast by Application (2023-2028) & (K Pcs) Table 94. Global Gastric Cancer Drugs Sales Market Share Forecast by Application (2023-2028) Table 95. Global Gastric Cancer Drugs Revenue Forecast by Application (2023-2028) & ($ Millions) Table 96. Global Gastric Cancer Drugs Revenue Market Share Forecast by Application (2023-2028) Table 97. Sanofi Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 98. Sanofi Gastric Cancer Drugs Product Offered Table 99. Sanofi Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 100. Sanofi Main Business Table 101. Sanofi Latest Developments Table 102. Eli Lilly Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 103. Eli Lilly Gastric Cancer Drugs Product Offered Table 104. Eli Lilly Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 105. Eli Lilly Main Business Table 106. Eli Lilly Latest Developments Table 107. F. Hoffmann-La Roche Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 108. F. Hoffmann-La Roche Gastric Cancer Drugs Product Offered Table 109. F. Hoffmann-La Roche Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 110. F. Hoffmann-La Roche Main Business Table 111. F. Hoffmann-La Roche Latest Developments Table 112. Otsuka Pharmaceutical Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 113. Otsuka Pharmaceutical Gastric Cancer Drugs Product Offered Table 114. Otsuka Pharmaceutical Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 115. Otsuka Pharmaceutical Main Business Table 116. Otsuka Pharmaceutical Latest Developments Table 117. Novartis Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 118. Novartis Gastric Cancer Drugs Product Offered Table 119. Novartis Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 120. Novartis Main Business Table 121. Novartis Latest Developments Table 122. Amgen Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 123. Amgen Gastric Cancer Drugs Product Offered Table 124. Amgen Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 125. Amgen Main Business Table 126. Amgen Latest Developments Table 127. Merck Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 128. Merck Gastric Cancer Drugs Product Offered Table 129. Merck Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 130. Merck Main Business Table 131. Merck Latest Developments Table 132. AstraZeneca Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 133. AstraZeneca Gastric Cancer Drugs Product Offered Table 134. AstraZeneca Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 135. AstraZeneca Main Business Table 136. AstraZeneca Latest Developments Table 137. Boehringer Ingelheim Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 138. Boehringer Ingelheim Gastric Cancer Drugs Product Offered Table 139. Boehringer Ingelheim Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 140. Boehringer Ingelheim Main Business Table 141. Boehringer Ingelheim Latest Developments Table 142. Daiichi-Sankyo Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 143. Daiichi-Sankyo Gastric Cancer Drugs Product Offered Table 144. Daiichi-Sankyo Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 145. Daiichi-Sankyo Main Business Table 146. Daiichi-Sankyo Latest Developments Table 147. Bayer HealthCare Basic Information, Gastric Cancer Drugs Manufacturing Base, Sales Area and Its Competitors Table 148. Bayer HealthCare Gastric Cancer Drugs Product Offered Table 149. Bayer HealthCare Gastric Cancer Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022) Table 150. Bayer HealthCare Main Business Table 151. Bayer HealthCare Latest Developments List of Figures Figure 1. Picture of Gastric Cancer Drugs Figure 2. Gastric Cancer Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Gastric Cancer Drugs Sales Growth Rate 2017-2028 (K Pcs) Figure 7. Global Gastric Cancer Drugs Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Gastric Cancer Drugs Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Doxorubicin Hydrochloride Figure 10. Product Picture of Sunitinib Figure 11. Product Picture of Docetaxel Figure 12. Product Picture of Mitomycin Figure 13. Product Picture of Fluorouracil Figure 14. Product Picture of Imatinib Figure 15. Product Picture of Trastuzumab Figure 16. Global Gastric Cancer Drugs Sales Market Share by Type in 2021 Figure 17. Global Gastric Cancer Drugs Revenue Market Share by Type (2017-2022) Figure 18. Gastric Cancer Drugs Consumed in Hospitals Figure 19. Global Gastric Cancer Drugs Market: Hospitals (2017-2022) & (K Pcs) Figure 20. Gastric Cancer Drugs Consumed in Clinics Figure 21. Global Gastric Cancer Drugs Market: Clinics (2017-2022) & (K Pcs) Figure 22. Gastric Cancer Drugs Consumed in Other Figure 23. Global Gastric Cancer Drugs Market: Other (2017-2022) & (K Pcs) Figure 24. Global Gastric Cancer Drugs Sales Market Share by Application (2017-2022) Figure 25. Global Gastric Cancer Drugs Revenue Market Share by Application in 2021 Figure 26. Gastric Cancer Drugs Revenue Market by Company in 2021 ($ Million) Figure 27. Global Gastric Cancer Drugs Revenue Market Share by Company in 2021 Figure 28. Global Gastric Cancer Drugs Sales Market Share by Geographic Region (2017-2022) Figure 29. Global Gastric Cancer Drugs Revenue Market Share by Geographic Region in 2021 Figure 30. Global Gastric Cancer Drugs Sales Market Share by Region (2017-2022) Figure 31. Global Gastric Cancer Drugs Revenue Market Share by Country/Region in 2021 Figure 32. Americas Gastric Cancer Drugs Sales 2017-2022 (K Pcs) Figure 33. Americas Gastric Cancer Drugs Revenue 2017-2022 ($ Millions) Figure 34. APAC Gastric Cancer Drugs Sales 2017-2022 (K Pcs) Figure 35. APAC Gastric Cancer Drugs Revenue 2017-2022 ($ Millions) Figure 36. Europe Gastric Cancer Drugs Sales 2017-2022 (K Pcs) Figure 37. Europe Gastric Cancer Drugs Revenue 2017-2022 ($ Millions) Figure 38. Middle East & Africa Gastric Cancer Drugs Sales 2017-2022 (K Pcs) Figure 39. Middle East & Africa Gastric Cancer Drugs Revenue 2017-2022 ($ Millions) Figure 40. Americas Gastric Cancer Drugs Sales Market Share by Country in 2021 Figure 41. Americas Gastric Cancer Drugs Revenue Market Share by Country in 2021 Figure 42. United States Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 43. Canada Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 44. Mexico Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 45. Brazil Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 46. APAC Gastric Cancer Drugs Sales Market Share by Region in 2021 Figure 47. APAC Gastric Cancer Drugs Revenue Market Share by Regions in 2021 Figure 48. China Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 49. Japan Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 50. South Korea Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 51. Southeast Asia Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 52. India Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 53. Australia Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 54. Europe Gastric Cancer Drugs Sales Market Share by Country in 2021 Figure 55. Europe Gastric Cancer Drugs Revenue Market Share by Country in 2021 Figure 56. Germany Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 57. France Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 58. UK Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 59. Italy Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 60. Russia Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 61. Middle East & Africa Gastric Cancer Drugs Sales Market Share by Country in 2021 Figure 62. Middle East & Africa Gastric Cancer Drugs Revenue Market Share by Country in 2021 Figure 63. Egypt Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 64. South Africa Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 65. Israel Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 66. Turkey Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 67. GCC Country Gastric Cancer Drugs Revenue Growth 2017-2022 ($ Millions) Figure 68. Manufacturing Cost Structure Analysis of Gastric Cancer Drugs in 2021 Figure 69. Manufacturing Process Analysis of Gastric Cancer Drugs Figure 70. Industry Chain Structure of Gastric Cancer Drugs Figure 71. Channels of Distribution Figure 72. Distributors Profiles
Sanofi Eli Lilly F. Hoffmann-La Roche Otsuka Pharmaceutical Novartis Amgen Merck AstraZeneca Boehringer Ingelheim Daiichi-Sankyo Bayer HealthCare
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape